Cyclosporine-A induced neurotoxicity after renal transplantation

Acta Neurologica Belgica

Volumn 101, Issue 2, 2001, Pages 124-127

  Derici, Ulver ^a   Arinsoy, Turgay ^a   Sindel, Sukru ^a   Tali, Turgut ^b   Leventoglu, Alev ^a   Sert, Sevki ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Di kapi Yildirim Beyazit Training and Research   (Turkey)

Author keywords

Cyclosporine A; MRI; Neurotoxicity; Renal transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; NEUROPEPTIDE; NEUROTOXIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; DRUG WITHDRAWAL; ENDOTHELIUM LESION; FEMALE; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; HYPOCHOLESTEROLEMIA; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; PATHOGENESIS;

EID: 0034883404     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. BORLAND I. A., GOSNEY J. R., HILLIS A. N., WILLIAMSON E. P. M., SELLS R. A. Hypomangesaemia and cyclosporin toxicity. Lancet, 1985, 12 : 103-104.
2. COLEY S. C., PORTER D. A., CALAMANTE F., CHONG W. K., CONNELY A. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR, 1999, 20 : 1507-1510.
3. DEBAERE C., STADNIK T., DE MAESENEER M., OSTEAUX M. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema. Eur. Radiol., 1999, 9 : 1916-1918.
4. DRACHMAN B. M., DENOFRIO D., ACKER M. A., GALETTA S., LOH E. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation : a case report and review of the literature. J. Heart Lung Transplant, 1996, 15 : 1158-1164.
5. ERER B., POLCHI P., LUCARELLI G., ANGELUCCI E., BARONCIANI D. et al. CsA-associated neurotoxicity and ineffective prophlaxis with clonazepam in patients transplanted for thalassemia major : analysis of risk factors. Bone Marrow Transplant., 1996, 18 : 157-162.
6. ESTERL R. M., GUPTA N., GARVIN P. J. Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient. Clin. Neuropharmacol., 1996, 19 : 259-266.
7. GUTENBEEK J. M. M., VAN DEN BENT M. J., VECHT C. J. Cyclosporine neurotoxicity : a review. J. Neurol., 1999, 246 : 339-346.
8. IDILMAN R., DE MARIA N., KUGELMAS M., COLANTONI A., VAN THIEL D. H. Immunosuppressive druginduced leukoencephalopathy in patients with liver transplant. Eur. J. Gastroenterol. Hepatol., 1998, 10 (5) : 433-6.
9. MCMANUS P. R., O'HAIR D. P., SCHWEIGER J., BEITZINGER J., SIEGEL R. Cyclosporine-associated central neurotoxicity after heart transplantation. Ann. Thorac. Surg., 1992, 53 : 326-327.
10. MENEGAUX F., KEEFFE E. B., ANDREWS B. T., EGAWA H., MONGE H. et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation, 1994,58 : 447-50.
11. MUELLER A. R., PLATZ K. P., BECHSTEIN W. O., SCHATTENFROH N., STOLTENBURG-DIDINGER G. et al. Neurotoxicity after orthotopic liver transplantation. A Comparison between cyclosporine and FK-506. Transplantation, 1994, 58 : 155-169.
12. PALMER B. F., TOTO R. D. Severe neurologie toxicity induced by cyclosporine A in three renal transplant patients. Am. J. Kidney Dis., 1991, 18 : 116-121.
13. RYFFEL B., WOLRLY G., GREINER B., HAENDLER B., MIHATSCH J. et al. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology, 1991, 72 : 399-404.
14. THOMPSON C. B., JUNE C. H., SULLIVAN K. M., THOMAS E. D. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet, 1984, 17 : 1116-1120.